Compare Lemonade Inc (LMND) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Lemonade Inc vs Regeneron Pharmaceuticals Inc — how do they compare? Lemonade Inc trades at $52.82 (market cap $4.09B), while Regeneron Pharmaceuticals Inc trades at $794.9 (market cap $82.06B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 20.1× Lemonade Inc's market cap, and Regeneron Pharmaceuticals Inc pays a 0.47% dividend while Lemonade Inc pays none. Which is the better fit depends on your goals.
| LMND | REGN | |
|---|---|---|
Market Cap | $4.09B | $82.06B |
Sector | Financials | Health |
52-Week High | $96.57 | $812.27 |
52-Week Low | $47.38 | $555.51 |
Enterprise Value | $3.95B | $76.77B |
Dividend Yield | — | 0.47% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Lemonade Inc
Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes.
Read more on LMND →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
